Last reviewed · How we verify
Beletalent (Zhuhai) Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| TNTL simulation preparation | TNTL simulation preparation | phase 3 | Psychiatry |
Therapeutic area mix
- Psychiatry · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
Subscribe to ongoing alerts
Every new pipeline event for Beletalent (Zhuhai) Pharmaceutical Co., Ltd:
- Beletalent (Zhuhai) Pharmaceutical Co., Ltd pipeline updates — RSS
- Beletalent (Zhuhai) Pharmaceutical Co., Ltd pipeline updates — Atom
- Beletalent (Zhuhai) Pharmaceutical Co., Ltd pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Beletalent (Zhuhai) Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beletalent-zhuhai-pharmaceutical-co-ltd. Accessed 2026-05-17.